Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial

(MedPage Today) — ATLANTA — Oral tebipenem pivoxil (TBP-PI) was non-inferior to IV imipenem-cilastatin (IMI-CIL) for treating complicated urinary tract infections (cUTI), including acute pyelonephritis (AP), according to a phase III trial…

Source link : https://www.medpagetoday.com/meetingcoverage/idweek/118144

Author :

Publish date : 2025-10-25 14:25:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial

Who Benefits From the MAHA Anti-Science Push?

ACOG President: Changing Tylenol’s Label Will Drive Baseless Fear

Related Posts

Food Allergies’ Psychosocial Toll on Families Often Missed

Nurse-Led IBD Care Cuts Hospital Burden

Older Adults With Dementia Face More Challenges After Injury

IBD, BMI May Play a Role in Hidradenitis Suppurativa Risk

Tirzepatide Matches Competitor’s Cardioprotective Benefits for Diabetics

Gout and Its Comorbidities

Food Allergies’ Psychosocial Toll on Families Often Missed

Nurse-Led IBD Care Cuts Hospital Burden

Older Adults With Dementia Face More Challenges After Injury

IBD, BMI May Play a Role in Hidradenitis Suppurativa Risk

Tirzepatide Matches Competitor’s Cardioprotective Benefits for Diabetics

Gout and Its Comorbidities

Combination Model May Improve Diagnosis of Serious Respiratory Infections

High-Fat Cheese May Have Cognitive Benefit, Study Suggests

Categories

Archives